0000902664-16-008843.txt : 20161116
0000902664-16-008843.hdr.sgml : 20161116
20161116170952
ACCESSION NUMBER: 0000902664-16-008843
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161114
FILED AS OF DATE: 20161116
DATE AS OF CHANGE: 20161116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TETRALOGIC PHARMACEUTICALS Corp
CENTRAL INDEX KEY: 0001361248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 1305
CITY: PAOLI
STATE: NY
ZIP: 19301
BUSINESS PHONE: 610-889-9900
MAIL ADDRESS:
STREET 1: P.O. BOX 1305
CITY: PAOLI
STATE: NY
ZIP: 19301
FORMER COMPANY:
FORMER CONFORMED NAME: TETRALOGIC PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20060501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HIGHBRIDGE CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0000919185
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36208
FILM NUMBER: 162003102
BUSINESS ADDRESS:
STREET 1: 40 WEST 57TH ST.
STREET 2: 32ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 2122874900
MAIL ADDRESS:
STREET 1: 40 WEST 57TH ST.
STREET 2: 32ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER NAME:
FORMER CONFORMED NAME: HIGHBRIDGE CAPITAL MANAGEMENT INC /NY
DATE OF NAME CHANGE: 19980610
FORMER NAME:
FORMER CONFORMED NAME: DUBIN & SWIECA ASSET MANAGEMENT INC
DATE OF NAME CHANGE: 19950817
4
1
p16-2179form4.xml
TETRALOGIC PHARMACEUTICALS CORPORATION
X0306
4
2016-11-14
1
0001361248
TETRALOGIC PHARMACEUTICALS Corp
TLOG
0000919185
HIGHBRIDGE CAPITAL MANAGEMENT LLC
40 WEST 57TH ST.
32ND FLOOR
NEW YORK
NY
10019
0
0
0
1
See Remarks
The Reporting Person is filing this Form 4 to exit the Section 16 reporting system because on November 14, 2016, the Reporting Person waived its right to convert any of the principal amount of the 8% Senior Convertible Notes due 2019 (the "Senior Notes") into shares of the Issuer's common stock, par value $0.0001 per share unless and until the date upon which the Issuer receives a milestone or earn-out payment pursuant to Section 3.2 or Section 3.3 of the APA (as defined in the Reporting Person's Form 3 filed on November 14, 2016) (or other payment in lieu thereof).
The Reporting Person expressly disclaims having been a member in a "group", within the meaning of Section 13(d) of the Securities Exchange Act of 1934, as amended, with the other holders of the Senior Notes (the "Other Noteholders") or any other person. In addition, the Reporting Person disclaims beneficial ownership of any shares of Common Stock beneficially owned by the Other Noteholders. However, if the Reporting Person was found to have been a member of a group with the Other Noteholders by virtue of the events described in the Schedule 13D filed by the Reporting Person on November 14, 2016, then, based on information and belief, such group would have beneficially owned in excess of 10% of the Issuer's Common Stock prior to the conversion waiver described above.
/s/ Highbridge Capital Management, LLC; By: John Oliva, its Managing Director
2016-11-16